L M Hess

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. ncbi request reprint Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures
    Lisa M Hess
    Arizona Cancer Center, University of Arizona, Tucson, 85724, USA
    Ann Pharmacother 40:1280-88. 2006
  2. ncbi request reprint Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid
    Lisa M Hess
    Arizona Cancer Center, University of Arizona Health Sciences Center, 1515 North Campbell Avenue, POB 245024, Tucson, AZ 85724 5024, USA
    Cancer Epidemiol Biomarkers Prev 13:861-7. 2004
  3. ncbi request reprint A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer
    L M Hess
    Arizona Cancer Center, College of Medicine, University of Arizona, Tucson, Arizona, USA
    Int J Gynecol Cancer 17:561-70. 2007
  4. ncbi request reprint Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancer
    Lisa M Hess
    Arizona Cancer Center, University of Arizona, P O Box 245024, 1515 North Campbell Avenue, 2964A1 Tucson, AZ 85724, USA
    Cancer Epidemiol Biomarkers Prev 14:2579-83. 2005
  5. pmc Factors associated with osteonecrosis of the jaw among bisphosphonate users
    Lisa M Hess
    College of Medicine, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724 5024, USA
    Am J Med 121:475-483.e3. 2008
  6. pmc Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study
    L M Hess
    Arizona Cancer Center, University of Arizona, 1515 N Campbell Avenue, Room 2964G, PO Box 245024, Tucson, AZ 85724 5024, USA
    Gynecol Oncol 107:260-5. 2007
  7. pmc Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer
    D S Alberts
    University of Arizona, Arizona Cancer Center, 1515 N Campbell Avenue, POB 245024, Tucson, AZ 85724 5024, and Case Western Reserve University Hospital, USA
    Gynecol Oncol 103:783-92. 2006
  8. ncbi request reprint Karyometry of the colonic mucosa
    David S Alberts
    Arizona Cancer Center, College of Medicine, University of Arizona, 1515 North Campbell Avenue, Tucson, AZ 85724 5024, USA
    Cancer Epidemiol Biomarkers Prev 16:2704-16. 2007
  9. ncbi request reprint Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence
    David S Alberts
    Department of Medicine, Arizona Cancer Center, College of Public Health, University of Arizona, Tucson, AZ, USA
    J Natl Cancer Inst 97:846-53. 2005
  10. ncbi request reprint Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial
    David S Alberts
    Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724 5024, USA
    Cancer Epidemiol Biomarkers Prev 12:197-200. 2003

Detail Information

Publications14

  1. ncbi request reprint Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures
    Lisa M Hess
    Arizona Cancer Center, University of Arizona, Tucson, 85724, USA
    Ann Pharmacother 40:1280-88. 2006
    ..These measures have focused on improving the accuracy of adherence measures or clarifying the evaluation time frame. As a result, there are many measures used to assess adherence that may or may not be comparable or accurate...
  2. ncbi request reprint Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid
    Lisa M Hess
    Arizona Cancer Center, University of Arizona Health Sciences Center, 1515 North Campbell Avenue, POB 245024, Tucson, AZ 85724 5024, USA
    Cancer Epidemiol Biomarkers Prev 13:861-7. 2004
    ....
  3. ncbi request reprint A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer
    L M Hess
    Arizona Cancer Center, College of Medicine, University of Arizona, Tucson, Arizona, USA
    Int J Gynecol Cancer 17:561-70. 2007
    ..799 (95% CI: 0.702-0.910, P= 0.0007). These findings strongly support the incorporation of an IP cisplatin regimen to improve survival in the front-line treatment of stage III, optimally debulked ovarian cancer...
  4. ncbi request reprint Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancer
    Lisa M Hess
    Arizona Cancer Center, University of Arizona, P O Box 245024, 1515 North Campbell Avenue, 2964A1 Tucson, AZ 85724, USA
    Cancer Epidemiol Biomarkers Prev 14:2579-83. 2005
    ..This study evaluates the association between participant self-reported study diary records and the weight of the medication vessel at each study visit, in the setting of a phase IIb topical chemoprevention trial...
  5. pmc Factors associated with osteonecrosis of the jaw among bisphosphonate users
    Lisa M Hess
    College of Medicine, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724 5024, USA
    Am J Med 121:475-483.e3. 2008
    ..It is unclear if the risk factors associated with osteonecrosis of the jaw among cancer patients taking bisphosphonates also are possible risk factors among patients receiving these medications for other indications...
  6. pmc Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study
    L M Hess
    Arizona Cancer Center, University of Arizona, 1515 N Campbell Avenue, Room 2964G, PO Box 245024, Tucson, AZ 85724 5024, USA
    Gynecol Oncol 107:260-5. 2007
    ..We sought to explore the association between weight change during treatment and survival, as well as the association between pre-chemotherapy body mass index (BMI) and survival...
  7. pmc Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer
    D S Alberts
    University of Arizona, Arizona Cancer Center, 1515 N Campbell Avenue, POB 245024, Tucson, AZ 85724 5024, and Case Western Reserve University Hospital, USA
    Gynecol Oncol 103:783-92. 2006
    ..The proceedings of this workshop summarize both research trial results and practical implementation issues associated with intraperitoneal therapy discussed at this workshop...
  8. ncbi request reprint Karyometry of the colonic mucosa
    David S Alberts
    Arizona Cancer Center, College of Medicine, University of Arizona, 1515 North Campbell Avenue, Tucson, AZ 85724 5024, USA
    Cancer Epidemiol Biomarkers Prev 16:2704-16. 2007
    ..The study summarizes results of karyometric measurements in epithelial cells of the colorectal mucosa to document evidence of a field effect of preneoplastic development among patients with colorectal adenocarcinoma or adenoma...
  9. ncbi request reprint Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence
    David S Alberts
    Department of Medicine, Arizona Cancer Center, College of Public Health, University of Arizona, Tucson, AZ, USA
    J Natl Cancer Inst 97:846-53. 2005
    ..We conducted a phase III, double-blind placebo-controlled trial of UDCA to evaluate its ability to prevent colorectal adenoma recurrence...
  10. ncbi request reprint Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial
    David S Alberts
    Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724 5024, USA
    Cancer Epidemiol Biomarkers Prev 12:197-200. 2003
    ..Thus, the inability of the high WBF intervention to reduce colorectal adenoma recurrence may be a consequence of its lack of effect on fecal aqueous-phase secondary bile acid concentrations...
  11. ncbi request reprint Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial
    Elizabeth T Jacobs
    Arizona Cancer Center, University of Arizona, Tucson, Arizona 87516, USA
    Cancer Epidemiol Biomarkers Prev 11:906-14. 2002
    ....
  12. pmc Limits of detection of chemopreventive efficacy: karyometry of skin biopsies
    Peter H Bartels
    College of Optical Sciences and Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA
    Cancer Epidemiol Biomarkers Prev 17:1689-95. 2008
    ..This study was designed to establish estimates of the smallest effects due to chemopreventive intervention detectable by karyometry in skin biopsies...
  13. ncbi request reprint The role of intraperitoneal therapy in advanced ovarian cancer
    Lisa M Hess
    Arizona Cancer Center Tucson, Arizona, USA
    Oncology (Williston Park) 21:227-32; discussion 232, 235, 239-42. 2007
    ..When making a decision between i.p. and i.v. therapeutic options, the experience and preference of the oncologist are critical factors in determining appropriate therapy for each woman...
  14. ncbi request reprint Chemotherapy-related change in cognitive function: a conceptual model
    Lisa M Hess
    The College of Medicine, The Arizona Cancer Center, The University of Arizona, Tucson
    Oncol Nurs Forum 34:981-94. 2007
    ..To develop a conceptual model of chemotherapy-related changes in cognitive function...